Ocrevus Zunovo Injection, Solution
Product Images NDC 50242-554

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ocrevus Zunovo (NDC 50242-554). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genentech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Ocrevus 01)

A Kaplan-Meier curve chart depicting the proportion of patients having confirmed disability progression over time, comparing REBIF 44 mcg (solid line) and EVUS 600 mg (dashed line). The chart includes patient risk numbers at various time points and indicates a 40% reduction in risk of disability progression with EVUS versus REBIF.*

FDA Label Image

Figure 2 (Ocrevus 02)

A Kaplan-Meier survival curve chart depicting the proportion of patients with confirmed disability progression over time, comparing Ocrevus Zunovo 600 mg injection (n=488) to placebo (n=244). The x-axis represents time in weeks, and the y-axis shows the proportion of patients progressing. The chart includes risk tables for both groups and indicates a 24% reduction in risk for the Ocrevus group with hazard ratio and statistical values provided.*

FDA Label Image

Principal Display Panel (23 mL Vial Carton)

Label for Ocrevus Zunovo, an injection solution containing ocrelizumab and hyaluronidase. The label indicates a strength of 920 mg and 23,000 units per 23 mL in a single-dose vial. It specifies subcutaneous use only, with injection in the abdomen over approximately 10 minutes. The label includes directions for pharmacists to dispense a Medication Guide. Manufactured by Genentech, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.